Surgeons detail challenges in treating 'tranq' wounds amid Philadelphia's Xylazine crisis
A new study examining the treatment of xylazine-associated wounds in Philadelphia sheds light on the severe medical ...
Q4 2024 AVITA Medical Inc Earnings Call
Welcome to the AVITA Medical fourth-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference ...
Medical Adhesive Market Set For Strong Growth, Projected To Reach USD 20.9 Billion By 2032
Global Medical Adhesive Market size is expected to be worth around USD 20.9 Bn by 2032 from USD 11.3 Bn in 2023, growing at a CAGR of 7.3% Boasting a robust healthcare industry, technological ...
MediWound commences Phase III trial for venous leg ulcers treatment
MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...
MediWound Ltd.: MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx for Treatment of Venous Leg Ulcers
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...